中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
12期
174-175
,共2页
初诊2型糖尿病%门冬胰岛素30%阿卡波糖%胰岛功能
初診2型糖尿病%門鼕胰島素30%阿卡波糖%胰島功能
초진2형당뇨병%문동이도소30%아잡파당%이도공능
Newly diagnosed type 2 diabetes%Insulin aspart 30%Acarbose%Islet function
目的:探讨采用门冬胰岛素30联合阿卡波糖治疗初诊2型糖尿病后患者胰岛功能的变化。方法随机选取我院2012年11月~2014年9月期间收治的初诊2型糖尿病患者47例,采用门冬胰岛素30联合阿卡波糖对患者进行治疗,对治疗前后患者血糖水平、胰岛素β细胞功能的变化情况进行观察。结果患者经治疗后,其胰岛素分泌明显。
目的:探討採用門鼕胰島素30聯閤阿卡波糖治療初診2型糖尿病後患者胰島功能的變化。方法隨機選取我院2012年11月~2014年9月期間收治的初診2型糖尿病患者47例,採用門鼕胰島素30聯閤阿卡波糖對患者進行治療,對治療前後患者血糖水平、胰島素β細胞功能的變化情況進行觀察。結果患者經治療後,其胰島素分泌明顯。
목적:탐토채용문동이도소30연합아잡파당치료초진2형당뇨병후환자이도공능적변화。방법수궤선취아원2012년11월~2014년9월기간수치적초진2형당뇨병환자47례,채용문동이도소30연합아잡파당대환자진행치료,대치료전후환자혈당수평、이도소β세포공능적변화정황진행관찰。결과환자경치료후,기이도소분비명현。
Objective Investigate islet function in patients using insulin aspart 30 combined after acarbose therapy in newly diagnosed type 2 diabetes.MethodsRandomly selected in our hospital in November 2012 -2014 period September diagnosed 47 cases of type 2 diabetes, insulin aspart 30 combined use of acarbose treatment of patients, blood glucose levels before and after treatment in patients with insulin β-cell function the changes were observed.Results Patients after treatment, signiifcantly increased insulin secretion, IR decreased, IS significantly increased, the difference was significant (P<0.05).Conclusion Using insulin aspart 30 combined acarbose therapy in newly diagnosed type 2 diabetes, the effect is signiifcant, can effectively promote the recovery of patients with pancreatic islet cell function and control blood sugar levels, it is recommended to further promote in clinical practice.